Decoding the Transcriptional Landscape of Triple-Negative Breast Cancer Using Next-Generation Whole Transcriptome Sequencing

被引：0
|
作者：
Radovich, M.
Clare, S. E.
Sledge, G. W.
Pardo, I.
Mathieson, T.
Kassem, N.
Hancock, B. A.
Storniolo, A. M. V.
Rufenbarger, C.
Lillemoe, H. A.
Sun, J.
Henry, J. E.
Goulet, R.
Hilligoss, E. E.
Siddiqui, A. S.
Breu, H.
Sakarya, O.
Hyland, F. C.
Muller, M. W.
Popescu, L.
Zhu, J.
Hickenbotham, M.
Glasscock, J.
Ivan, M.
Liu, Y.
Schneider, B. P.
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN USA
[2] Life Technol Inc, Foster City, CA USA
[3] Cofactor Genom LLC, St Louis, MO USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-PD01-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD01-08
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms
    Chang, Yu-Cheng
    Lin, Huan-Chau
    Chiang, Yi-Hao
    Chen, Caleb Gon-Shen
    Huang, Ling
    Wang, Wei-Ting
    Cheng, Chun-Chia
    Lin, Johnson
    Chang, Yi-Fang
    Chang, Ming-Chih
    Hsieh, Ruey-Kuen
    Chen, Shu-Jen
    Lim, Ken-Hong
    Kuo, Yuan-Yeh
    MEDICAL ONCOLOGY, 2017, 34 (05)
  • [22] Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms
    Yu-Cheng Chang
    Huan-Chau Lin
    Yi-Hao Chiang
    Caleb Gon-Shen Chen
    Ling Huang
    Wei-Ting Wang
    Chun-Chia Cheng
    Johnson Lin
    Yi-Fang Chang
    Ming-Chih Chang
    Ruey-Kuen Hsieh
    Shu-Jen Chen
    Ken-Hong Lim
    Yuan-Yeh Kuo
    Medical Oncology, 2017, 34
  • [23] Transcriptome sequencing of triple negative breast cancer
    Nanba, Shinichi
    Kawazu, Masahito
    Kojima, Shinya
    Ueno, Toshihide
    Mano, Hiroyuki
    CANCER SCIENCE, 2018, 109 : 524 - 524
  • [24] Transcriptome Profiling Using Next-Generation Sequencing
    Asmann, Yan W.
    Wallace, Michael B.
    Thompson, E. Aubrey
    GASTROENTEROLOGY, 2008, 135 (05) : 1466 - 1468
  • [25] Transcriptome analysis using next-generation sequencing
    Mutz, Kai-Oliver
    Heilkenbrinker, Alexandra
    Loenne, Maren
    Walter, Johanna-Gabriela
    Stahl, Frank
    CURRENT OPINION IN BIOTECHNOLOGY, 2013, 24 (01) : 22 - 30
  • [26] Next-generation proteasome inhibitor oprozomib enhances sensitivity to doxorubicin in triple-negative breast cancer cells
    Shi, Yonghua
    Bieerkehazhi, Shayahati
    Ma, Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (05): : 2347 - 2355
  • [27] Next-generation sequencing reveals altered gene expression and enriched pathways in triple-negative breast cancer cells treated with oleuropein and oleocanthal
    Karousi, Paraskevi
    Kontos, Christos K.
    Papakotsi, Panagiota
    Kostakis, Ioannis K.
    Skaltsounis, Alexios-Leandros
    Scorilas, Andreas
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23 (04)
  • [28] Next-generation sequencing reveals altered gene expression and enriched pathways in triple-negative breast cancer cells treated with oleuropein and oleocanthal
    Paraskevi Karousi
    Christos K. Kontos
    Panagiota Papakotsi
    Ioannis K. Kostakis
    Alexios-Leandros Skaltsounis
    Andreas Scorilas
    Functional & Integrative Genomics, 2023, 23
  • [29] Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology
    Weisman, Paul S.
    Ng, Charlotte Ky
    Brogi, Edi
    Eisenberg, Rachel E.
    Won, Helen H.
    Piscuoglio, Salvatore
    De Filippo, Maria R.
    Ioris, Rafael
    Akram, Muzaffar
    Norton, Larry
    Weigelt, Britta
    Berger, Michael F.
    Reis-Filho, Jorge S.
    Wen, Hannah Y.
    MODERN PATHOLOGY, 2016, 29 (05) : 476 - 488
  • [30] The Proteomic Landscape of Triple-Negative Breast Cancer
    Lawrence, Robert T.
    Perez, Elizabeth M.
    Hernandez, Daniel
    Miller, Chris P.
    Haas, Kelsey M.
    Irie, Hanna Y.
    Lee, Su-In
    Blau, C. Anthony
    Villen, Judit
    CELL REPORTS, 2015, 11 (04): : 630 - 644
12345